Semaglutid

Semaglutid

Produktname Semaglutid
CAS-Nummer 910463-68-2
Molekülformel C187H291N45O59
Molekulargewicht 4113.58
Aussehen Weißes bis cremefarbenes Pulver
Reinheit (HPLC) ≥98%
Paket 5g, 10g, 50g per container

Brauchst du Hilfe? Kontaktieren Sie unser Team

Semaglutide Structure

Synonyms: Semaglutide, 910463-68-2, GLP-1 receptor agonist, GLP-1 analog, Semaglutide (USAN), Ozempic, Wegovy

Semaglutide is a synthetic analog of the human glucagon-like peptide-1 (GLP-1), a key incretin hormone that regulates glucose metabolism and appetite. It is a 31-amino acid peptide with a fatty acid side chain that enables extended half-life and once-weekly dosing. Developed for the treatment of type 2 diabetes and obesity, semaglutide has become a benchmark in the growing class of GLP-1 receptor agonists.

The molecule was engineered by substituting specific amino acids and attaching a C18 fatty diacid via a hydrophilic spacer, which promotes strong binding to albumin and slows renal clearance. This structural design allows for maintaining therapeutic concentrations over a week, a significant improvement over earlier GLP-1 analogs that required daily injections. Semaglutide is also being investigated for cardiovascular benefits and non-alcoholic steatohepatitis (NASH), reflecting its expanding clinical relevance.

As a research-grade peptide, semaglutide is supplied for laboratory use, including preclinical studies, analytical method development, and formulation research. It is typically offered as a lyophilized powder with a purity of at least 98% by HPLC, ensuring reliable performance in a range of experimental settings.

Funktion

  • GLP-1 receptor activation: Stimulates insulin secretion in a glucose-dependent manner.
  • Appetitregulierung: Reduces food intake and promotes satiety.
  • Beta-cell protection: Supports pancreatic beta-cell function.
  • Cardiovascular benefits: May lower risk of major adverse cardiovascular events.

Quelle und Standardisierung

  • Quelle: Synthetic peptide, manufactured via solid-phase peptide synthesis.
  • Gewinnung: Not applicable; produced by chemical synthesis.
  • Standardisierung: Purity ≥98% by HPLC; identity confirmed by mass spectrometry.
  • Formulare: Lyophilized powder (as acetate or TFA salt).
  • Anwendungen: Research use only; not for human or veterinary use.

Technische Daten

Parameter Technische Daten
Analyse (HPLC) ≥98,01 TP3T
Aussehen Weißes bis cremefarbenes Pulver
Water Content (KF) ≤8.0%
Acetate Content (if applicable) 5.0–12.0%
Endotoxin Level ≤5 EU/mg

Dokumentation und Lieferung

  • Monatliche Kapazität: 5 kg
  • Lieferzeit: 5–10 working days after order confirmation
  • Dokumentation: COA, Sicherheitsdatenblatt, Technisches Datenblatt
  • Verpackung: Double polyethylene bags inside aluminum foil bag; custom packaging available

Angebotsanfrage

  • Unsere Adresse: 280 Main Street, Xi’an, Shaanxi, China
  • LyvBio GmbH. — E-Mail: info@lyvbio.com

BLEIBEN SIE IN KONTAKT

Angebotsanfrage

Unsere Adresse

Hauptstraße 280, Xi’an, Shaanxi, China

×